Referanslar

1. Blom AW, Lenguerrand E, Strange S, Noble SM, Beswick AD, Burston A, et al. Clinical and cost effectiveness of sin- gle stage compared with two stage revision for hip prosthetic joint infection (INFORM): pragmatic, parallel group, open label, randomised controlled trial. bmj. 2022;379. [Crossref]  [PubMed]  [PMC]
2. Gehrke T, Zahar A, Kendoff D. One-stage exchange: it all began here. The bone & joint journal. 2013;95(11_ Supple_A):77-83. [Crossref]  [PubMed]
3. Jenny J-Y, Lengert R, Diesinger Y, Gaudias J, Boeri C, Kempf J-F. Routine one-stage exchange for chronic infection after total hip replacement. International orthopaedics. 2014;38:2477-81. [Crossref]  [PubMed]
4. Haddad F, Muirhead-Allwood S, Manktelow A, Baca- rese-Hamilton I. Two-stage uncemented revision hip ar- throplasty for infection. The Journal of Bone & Joint Surgery British Volume. 2000;82(5):689-94. [Crossref]
5. Chen S-Y, Hu C-C, Chen C-C, Chang Y-H, Hsieh P-H. Two- stage revision arthroplasty for periprosthetic hip infection: mean follow-up of ten years. BioMed research international. 2015;2015(1):345475. [Crossref]  [PubMed]  [PMC]
6. Otten MR, Kildow BJ, Sayles HR, Drummond D, Garvin KL. Two-stage reimplantation of a prosthetic hip infection: systematic review of long-term reinfection and pathogen outcomes. The Journal of Arthroplasty. 2021;36(7):2630-41. [Crossref]  [PubMed]
7. Klouche S, Sariali E, Mamoudy P. Total hip arthroplasty re- vision due to infection: a cost analysis approach. Orthopae- dics & Traumatology: Surgery & Research. 2010;96(2):124-32. [Crossref]
8. Parvizi J, Tan TL, Goswami K, Higuera C, Della Valle C, Chen AF, et al. The 2018 definition of periprosthetic hip and knee infection: an evidence-based and validated criteria. The Journal of arthroplasty. 2018;33(5):1309-14. e2. [Crossref]  [PubMed]
9. Tan TL, Parvizi J. Periprosthetic Joint Infection: Consensus and Guidelines. Essentials of Cemented Knee Arthroplasty. 2022:653-9. [Crossref]
10. Levine BR, Della Valle CJ, Hamming M, Sporer SM, Berg- er RA, Paprosky WG. Use of the extended trochanteric os- teotomy in treating prosthetic hip infection. The Journal of Arthroplasty. 2009;24(1):49-55. [Crossref]  [PubMed]
11. Lim S-J, Moon Y-W, Park Y-S. Is extended trochanteric os- teotomy safe for use in 2-stage revision of periprosthetic hip infection? The Journal of Arthroplasty. 2011;26(7):1067-71. [Crossref]  [PubMed]
12. Cacciola G, Giustra F, Bosco F, Aprato A, De Meo F, Cava- liere P, et al. Extended trochanteric osteotomy is a safe pro- cedure in two-stage hip revision: a systematic review of the literature. European Journal of Orthopaedic Surgery & Trau- matology. 2023;33(7):2695-702. [Crossref]  [PubMed]  [PMC]
13. Calkins TE, Culvern C, Nam D, Gerlinger TL, Levine BR, Sporer SM, et al. Dilute betadine lavage reduces the risk of acute postoperative periprosthetic joint infection in aseptic revision total knee and hip arthroplasty: a randomized con- trolled trial. The Journal of Arthroplasty. 2020;35(2):538-43. e1. [Crossref]  [PubMed]
14. Hart A, Hernandez NM, Abdel MP, Mabry TM, Hanssen AD, Perry KI. Povidone-iodine wound lavage to prevent infec- tion after revision total hip and knee arthroplasty: an anal- ysis of 2,884 cases. JBJS. 2019;101(13):1151-9. [Crossref]  [PubMed]
15. Kobayashi N, Kamono E, Maeda K, Misumi T, Yukizawa Y, Inaba Y. Effectiveness of diluted povidone-iodine lavage for preventing periprosthetic joint infection: an updated sys- tematic review and meta-analysis. Journal of orthopaedic surgery and research. 2021;16:1-9. [Crossref]  [PubMed]  [PMC]
16. Van Meurs S, Gawlitta D, Heemstra K, Poolman R, Vo- gely H, Kruyt M. Selection of an optimal antiseptic solu- tion for intraoperative irrigation: an in vitro study. JBJS. 2014;96(4):285-91. [Crossref]  [PubMed]
17. Brown NM, Cipriano CA, Moric M, Sporer SM, Della Valle CJ. Dilute betadine lavage before closure for the prevention of acute postoperative deep periprosthetic joint infection. The Journal of arthroplasty. 2012;27(1):27-30. [Crossref]  [PubMed]
18. Limtong J, Pannu TS, Villa JM, Riesgo AM, Higuera CA. Comparison of outcomes between static spacers versus artic- ulating spacers in the setting of revision periprosthetic knee infections: A systematic review. Annals of Joint. 2021;6. [Crossref]
19. Rava A, Bruzzone M, Cottino U, Enrietti E, Rossi R. Hip spacers in two-stage revision for periprosthetic joint in- fection: a review of literature. Joints. 2019;7(02):056-63. [Crossref]  [PubMed]  [PMC]
20. Charette RS, Melnic CM. Two-stage revision arthroplasty for the treatment of prosthetic joint infection. Current re- views in musculoskeletal medicine. 2018;11:332-40. [Crossref]  [PubMed]  [PMC]
21. Jacobs C, Christensen CP, Berend ME. Static and mobile antibiotic-impregnated cement spacers for the management of prosthetic joint infection. JAAOS-Journal of the Ameri- can Academy of Orthopaedic Surgeons. 2009;17(6):356-68. [Crossref]  [PubMed]
22. Anagnostakos K. Therapeutic use of antibiotic-loaded bone cement in the treatment of hip and knee joint infections. Journal of bone and joint infection. 2017;2(1):29-37. [Crossref]  [PubMed]  [PMC]
23. Citak M, Masri BA, Springer B, Argenson J-N, Kendoff DO. Are preformed articulating spacers superior to surgeon-made articulating spacers in the treatment of PJI in THA? A liter- ature review. The Open Orthopaedics Journal. 2015;9:255. [Crossref]  [PubMed]  [PMC]
24. Goltzer O, McLaren A, Overstreet D, Galli C, McLemore R. Antimicrobial release from prefabricated spacers is vari- able and the dose is low. Clinical Orthopaedics and Related Research®. 2015;473(7):2253-61. [Crossref]  [PubMed]  [PMC]
25. Bertazzoni Minelli E, Benini A, Magnan B, Bartolozzi P. Re- lease of gentamicin and vancomycin from temporary human hip spacers in two-stage revision of infected arthroplasty. Journal of Antimicrobial Chemotherapy. 2004;53(2):329-34. [Crossref]  [PubMed]
26. Nahhas CR, Chalmers PN, Parvizi J, Sporer SM, Deirmengian GK, Chen AF, et al. Randomized trial of static and articulating spacers for treatment of the infected total hip ar- throplasty. The Journal of arthroplasty. 2021;36(6):2171-7. [Crossref]  [PubMed]
27. Ammon P, Stockley I. Allograft bone in two-stage revision of the hip for infection: IS IT SAFE? The Journal of Bone & Joint Surgery British Volume. 2004;86(7):962-5. [Crossref]  [PubMed]
28. Sporer SM. Spacer design options and consideration for periprosthetic joint infection. The Journal of arthroplasty. 2020;35(3):S31-S4. [Crossref]  [PubMed]
29. Craig A, King S, van Duren B, Veysi V, Jain S, Palan J. Artic- ular spacers in two-stage revision arthroplasty for prosthetic joint infection of the hip and the knee. EFORT open reviews. 2022;7(2):137-52. [Crossref]  [PubMed]  [PMC]
30. Anagnostakos K, Kelm J. Enhancement of antibiotic elution from acrylic bone cement. Journal of Biomedical Materials Research Part B: Applied Biomaterials. 2009;90(1):467-75. [Crossref]  [PubMed]
31. Moran JM, Seth A, Matejczyk M-B. Effect of gentamicin on shear and interface strengths of bone cement. Clinical Orthopaedics and Related Research®. 1979 (141):96-101. [Crossref]
32. Anagnostakos K, Meyer C. Antibiotic elution from hip and knee acrylic bone cement spacers: a systematic review. BioMed research international. 2017;2017(1):4657874. [Crossref]  [PubMed]  [PMC]
33. Samelis PV, Papagrigorakis E, Sameli E, Mavrogenis A, Sav- vidou O, Koulouvaris P. Current concepts on the application, pharmacokinetics and complications of antibiotic-loaded ce- ment spacers in the treatment of prosthetic joint infections. Cureus. 2022;14(1). [Crossref]
34. Ghanem E, Azzam K, Seeley M, Joshi A, Parvizi J. Staged revision for knee arthroplasty infection: what is the role of serologic tests before reimplantation? Clinical Orthopaedics and Related Research®. 2009;467(7):1699-705. [Crossref]  [PubMed]  [PMC]
35. Kusuma SK, Ward J, Jacofsky M, Sporer SM, Della Valle CJ. What is the role of serological testing between stages of two- stage reconstruction of the infected prosthetic knee? Clinical Orthopaedics and Related Research®. 2011;469(4):1002-8. [Crossref]  [PubMed]  [PMC]
36. Wang R, Zhang H, Ding P, Jiao Q. The accuracy of D-dimer in the diagnosis of periprosthetic infections: a systematic re- view and meta-analysis. Journal of Orthopaedic Surgery and Research. 2022;17(1):99. [Crossref]  [PubMed]  [PMC]
37. Xu C, Qu P-F, Chai W, Li R, Chen J-Y. Plasma fibrinogen may predict persistent infection before reimplantation in two- stage exchange arthroplasty for periprosthetic hip infection. Journal of Orthopaedic Surgery and Research. 2019;14:1-7. [Crossref]  [PubMed]  [PMC]
38. Hoell S, Borgers L, Gosheger G, Dieckmann R, Schulz D, Gerss J, et al. Interleukin-6 in two-stage revision ar- throplasty: what is the threshold value to exclude per- sistent infection before re-implanatation? The bone & joint journal. 2015;97(1):71-5. [Crossref]  [PubMed]
39. Qu P-F, Xu C, Fu J, Li R, Chai W, Chen J-Y. Does serum in- terleukin-6 guide the diagnosis of persistent infection in two- stage hip revision for periprosthetic joint infection? Journal of Orthopaedic Surgery and Research. 2019;14:1-7. [Crossref]  [PubMed]  [PMC]
40. Boelch SP, Weissenberger M, Spohn F, Rudert M, Luede- mann M. Insufficient sensitivity of joint aspiration during the two-stage exchange of the hip with spacers. Journal of Orthopaedic Surgery and Research. 2018;13:1-6. [Crossref]  [PubMed]  [PMC]
41. Hoell S, Moeller A, Gosheger G, Hardes J, Dieckmann R, Schulz D. Two-stage revision arthroplasty for periprosthetic joint infections: what is the value of cultures and white cell count in synovial fluid and CRP in serum before second stage reimplantation? Archives of orthopaedic and trauma surgery. 2016;136:447-52. [Crossref]  [PubMed]
42. Macke C, Lenhof S, Graulich T, Oergel M, Omar-Pacha T, Stübig T, et al. Low diagnostic value of synovial aspiration culture prior to reimplantation in periprosthetic joint infec- tion. in vivo. 2021;35(4):2409-16. [Crossref]  [PubMed]  [PMC]
43. Mühlhofer HM, Knebel C, Pohlig F, Feihl S, Harrasser N, Schauwecker J, et al. Synovial aspiration and serological testing in two-stage revision arthroplasty for prosthetic joint infection: evaluation before reconstruction with a mean fol- low-up of twenty seven months. International Orthopaedics. 2018;42:265-71. [Crossref]  [PubMed]
44. Ascione T, Balato G, Mariconda M, Smeraglia F, Baldini A, De Franco C, et al. Synovial cell count before reimplanta- tion can predict the outcome of patients with periprosthet- ic knee infections undergoing two-stage exchange. Clinical Orthopaedics and Related Research®. 2021;479(9):2061-8. [Crossref]  [PubMed]  [PMC]
45. Stone WZ, Gray CF, Parvataneni HK, Prieto HA. Clinical evaluation of alpha defensin test following staged treat- ment of prosthetic joint infections. The Journal of Arthro- plasty. 2019;34(7):1446-51. [Crossref]  [PubMed]
46. Owens JM, Dennis DA, Abila PM, Johnson RM, Jennings JM. Alpha-defensin offers limited utility in work-up pri- or to reimplantation in chronic periprosthetic joint infec- tion in total joint arthroplasty patients. The Journal of Arthroplasty. 2022;37(12):2431-6. [Crossref]  [PubMed]
47. Carli AV, Abdelbary H, Ahmadzai N, Cheng W, Shea B, Hutton B, et al. Diagnostic accuracy of serum, synovial, and tissue testing for chronic periprosthetic joint infection after hip and knee replacements: a systematic review. JBJS. 2019;101(7):635-49. [Crossref]  [PubMed]
48. Insall JN, Thompson F, Brause B. Two-stage reimplantation for the salvage of infected total knee arthroplasty. JBJS. 1983;65(8):1087-98. [Crossref]
49. Kuzyk PR, Dhotar HS, Sternheim A, Gross AE, Safir O, Backstein D. Two-stage revision arthroplasty for man- agement of chronic periprosthetic hip and knee infection: techniques, controversies, and outcomes. JAAOS-Jour- nal of the American Academy of Orthopaedic Surgeons. 2014;22(3):153-64. [Crossref]  [PubMed]
50. Olearo F, Zanichelli V, Exarchakou A, Both A, Ukay I, Aepfelbacher M, et al., editors. The impact of antimicrobial therapy duration in the treatment of prosthetic joint infec- tions depending on surgical strategies: a systematic review and meta-analysis. Open forum infectious diseases; 2023: Oxford University Press US. [Crossref]  [PubMed]  [PMC]
51. Tan TL, Kheir MM, Rondon AJ, Parvizi J, George J, Higuera CA, et al. Determining the role and duration of the "anti- biotic holiday" period in periprosthetic joint infection. The Journal of Arthroplasty. 2018;33(9):2976-80. [Crossref]  [PubMed]
52. Birlutiu RM, Mihalache M, Mihalache P, Cismasiu RS, Bir- lutiu V. Mid-term follow-up results after implementing a new strategy for the diagnosis and management of periprosthetic joint infections. BMC Infectious Diseases. 2021;21:1-10. [Crossref]  [PubMed]  [PMC]
53. Warth LC, Hadley CJ, Grossman EL. Two-stage treatment for total knee arthroplasty infection utilizing an articu- lating prefabricated antibiotic spacer. The Journal of ar- throplasty. 2020;35(3):S57-S62. [Crossref]  [PubMed]
54. Rezaie AA, Goswami K, Shohat N, Tokarski AT, White AE, Parvizi J. Time to reimplantation: waiting longer confers no added benefit. The Journal of Arthroplasty. 2018;33(6):1850-4. [Crossref]  [PubMed]
55. Vielgut I, Sadoghi P, Wolf M, Holzer L, Leithner A, Schwantzer G, et al. Two-stage revision of prosthetic hip joint infections using antibiotic-loaded cement spacers: when is the best time to perform the second stage? Internation- al Orthopaedics. 2015;39:1731-6. [Crossref]  [PubMed]
56. Puetzler J, Schulze M, Gosheger G, Schwarze J, Moellen- beck B, Theil C. Is long time to reimplantation a risk fac- tor for reinfection in two-stage revision for periprosthetic infection? A systematic review of the literature. Frontiers in Surgery. 2023;10:1113006. [Crossref]  [PubMed]  [PMC]
57. Della Valle CJ, Bogner E, Desai P, Lonner JH, Adler E, Zuck- erman JD, et al. Analysis of frozen sections of intraoperative specimens obtained at the time of reoperation after hip or knee resection arthroplasty for the treatment of infection. JBJS. 1999;81(5):684-9. [Crossref]  [PubMed]
58. Bori G, Soriano A, García S, Mallofré C, Riba J, Mensa J. Usefulness of histological analysis for predicting the pres- ence of microorganisms at the time of reimplantation after hip resection arthroplasty for the treatment of infection. JBJS. 2007;89(6):1232-7. [Crossref]  [PubMed]
59. Li C, Renz N, Trampuz A, Ojeda-Thies C. Twenty common errors in the diagnosis and treatment of periprosthetic joint infection. International orthopaedics. 2020;44:3-14. [Crossref]  [PubMed]  [PMC]